Odypharm India Private Limited
About Odypharm India Private Limited
Data last updated:
Odypharm India Private Limited is a private limited company based in Nagpur, Maharashtra, India, a subsidiary of Odypharm Life Sciences Hong Kong Limited. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 06 March 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Nagpur, under CIN U24100MH2009PTC190795. Its GSTIN is 27AABCO1406G1ZV (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Santosh Deshpande (Managing Director) and Ulhasrao Sitaram Deshpande.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Block No. 101 Plot No.288 Katol Bypass Ring Road Tawakkal Layout Wadi, Nagpur, Maharashtra, India – 440023.
As per the financials filed for FY 2024, the company reported a revenue of ₹9.67 Cr, a growth of 28% compared to the previous year. For the same year it recorded a net profit of ₹83.23 Lakh (net margin 8.6%) and EBITDA of ₹1.23 Cr (EBITDA margin 12.7%). Revenue has grown at a compounded annual rate (CAGR) of 20% over three years and 3% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Odypharm India Private Limited's registered office is in Nagpur, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressBlock No. 101 Plot No.288 Katol Bypass Ring Road Tawakkal Layout Wadi, Nagpur, Maharashtra, India – 440023
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Odypharm India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Odypharm India is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Odypharm India Private Limited, buy the company report.
Financials of Odypharm India Private Limited
FY 2024 filings availableOdypharm India Private Limited reported revenue of ₹9.67 Cr (up 28% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 3% over five years, including 28% growth in the latest year. EBITDA rose 82% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.23 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹83.23 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.7% | ||||
| Net Profit Margin | 8.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Odypharm India Private Limited, buy the company report.
Board of directors of Odypharm India Private Limited
Odypharm India has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Santosh Deshpande Also directs: Bda Health Care Private Limited, Bda Pharma Private Limited, Bda Laboratories Private Limited and 2 more | Managing Director | 06 Mar 2009 | 17 Years 7 Months | Current |
| Ulhasrao Sitaram Deshpande | Director | 20 May 2013 | 13 Years 5 Months | Current |
Auditor
Odypharm India Private Limited is audited by ALI HATIM & CO for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ALI HATIM & CO | FY 2018 | 135382W |
Shareholding
The shareholding of Odypharm India Private Limited is on record for 3 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Odypharm India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Odypharm India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Odypharm India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Odypharm India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCO1406G1ZV | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Odypharm India Private Limited, buy the company report.
Recent activity
Odypharm India Private Limited has 5 board changes on record since 2009: 2 appointments and 3 cessations. The latest: Santosh Deshpande ceased to be Director on 01 Oct 2013.
Frequently asked questions
Odypharm India is an active private limited company based in Nagpur, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 06 March 2009 (17+ years old) and is registered under CIN U24100MH2009PTC190795.
Odypharm India has 2 current directors:
- Santosh Deshpande - Managing Director
- Ulhasrao Sitaram Deshpande - Director
The latest financial statements of Odypharm India on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Odypharm India is 27AABCO1406G1ZV, registered in Maharashtra.
The CIN (Corporate Identification Number) of Odypharm India is U24100MH2009PTC190795. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Odypharm India was incorporated on 06 March 2009, making it 17+ years old. It is registered with the Registrar of Companies, Nagpur.
Santosh Deshpande ceased to be Director on 01 Oct 2013. Sayali Santosh Deshpande ceased to be Director on 30 Sep 2013. Ulhasrao Sitaram Deshpande ceased to be Additional Director on 30 Sep 2013. Odypharm India has 5 board changes on record in total.
The registered office of Odypharm India is at Block No. 101 Plot No.288 Katol Bypass Ring Road Tawakkal Layout Wadi, Nagpur, Maharashtra, India – 440023.
Odypharm India operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Odypharm India is compliant as of 01 September 2026. The company is actively filing with the Registrar of Companies.